[On the question of drug-induced pseudo-LE syndrome: preliminary results in 58 cases (author's transl)].
Drug intake had been checked in 58 patients with pseudo-LE-syndrome. In view of the findings of the Zürich group a connection between the intake of Venopyronum¿ coated tablets and a pseudo-LE syndrome was strongly suspected in 45. In a further seven patients who also had taken the drug no definite connection could be shown because there was no temporal relationship between drug and disease. Three patients had taken Venopyronum-triplex capsules. Only three patients categorically denied ever having taken the drug in any form.
D000208:Acute Disease; D000328:Adult; D000368:Aged; D000917:Antibody Formation; D005260:Female; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced* / Q000276:immunology; D008297:Male; D008875:Middle Aged; D008928:Mitochondria / Q000276:immunology; D010653:Phenylbutazone / Q000031:analogs & derivatives; D011720:Pyrazoles / Q000008:administration & dosage / Q000009:adverse effects*; D013997:Time Factors
D011720:Pyrazoles; C010619:phenopyrazone; D010653:Phenylbutazone
Zur Frage einer Induzierbarkeit des Pseudo-LE-Syndroms durch Arzneimittel. Vorläufige Ergebnisse von Erhebungen bei 58 Fällen